Canada markets open in 4 hours 55 minutes

Clinuvel Pharmaceuticals Limited (CUV.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
15.38-0.32 (-2.04%)
At close: 04:10PM AEST
Currency in AUD

Valuation Measures4

Market Cap (intraday) 786.63M
Enterprise Value 613.25M
Trailing P/E 27.40
Forward P/E 19.05
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)10.22
Price/Book (mrq)4.40
Enterprise Value/Revenue 7.55
Enterprise Value/EBITDA 12.09

Trading Information

Stock Price History

Beta (5Y Monthly) 0.92
52-Week Change 3-8.83%
S&P500 52-Week Change 324.96%
52 Week High 321.45
52 Week Low 312.96
50-Day Moving Average 315.10
200-Day Moving Average 315.44

Share Statistics

Avg Vol (3 month) 396.33k
Avg Vol (10 day) 384.71k
Shares Outstanding 550.1M
Implied Shares Outstanding 650.1M
Float 839.49M
% Held by Insiders 120.44%
% Held by Institutions 18.93%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.05
Forward Annual Dividend Yield 40.32%
Trailing Annual Dividend Rate 30.05
Trailing Annual Dividend Yield 30.32%
5 Year Average Dividend Yield 40.16
Payout Ratio 48.73%
Dividend Date 3N/A
Ex-Dividend Date 4Sept 05, 2023
Last Split Factor 21:10
Last Split Date 3Nov 12, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 36.88%
Operating Margin (ttm)42.37%

Management Effectiveness

Return on Assets (ttm)14.71%
Return on Equity (ttm)18.98%

Income Statement

Revenue (ttm)81.76M
Revenue Per Share (ttm)1.65
Quarterly Revenue Growth (yoy)11.70%
Gross Profit (ttm)N/A
EBITDA 44.36M
Net Income Avi to Common (ttm)30.15M
Diluted EPS (ttm)0.57
Quarterly Earnings Growth (yoy)-4.00%

Balance Sheet

Total Cash (mrq)174.45M
Total Cash Per Share (mrq)3.52
Total Debt (mrq)1.07M
Total Debt/Equity (mrq)0.60%
Current Ratio (mrq)6.86
Book Value Per Share (mrq)3.61

Cash Flow Statement

Operating Cash Flow (ttm)42.27M
Levered Free Cash Flow (ttm)31.29M